H.R. 4106 – Test Strip Access Act of 2023

AI-Generated Summary

Updated January 20, 2026 at 8:57 AM UTC

The Test Strip Access Act of 2023 changes the 21st Century Cures Act so that federal grant programs can specifically fund the purchase and distribution of fentanyl and xylazine test strips. This aims to help state and tribal programs prevent substance‑use disorders and overdoses by making these testing tools more available. The bill affects agencies that award grants for opioid‑related health initiatives and the communities they serve.

Key Provisions

Amends Section 1003(b)(4)(A) of the 21st Century Cures Act to add “or fentanyl or xylazine test strips” to the list of items that grant funds may cover, explicitly authorizing use of grants for these test strips.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

2 earlier actions

HouseCommittee Latest Action

Referred to the Subcommittee on Health.

Health Subcommittee

June 16, 2023

View full timeline

HouseIntro Referral

Introduced in House

June 14, 2023

HouseIntro Referral

Referred to the House Committee on Energy and Commerce.

Energy and Commerce Committee

June 14, 2023

HouseCommittee

Referred to the Subcommittee on Health.

Health Subcommittee

June 16, 2023

Bill Text

Latest available legislative text

Reading Mode

Raw Text PDF XML

Introduced in HouseIssued June 14, 2023

I

118th CONGRESS

1st Session

H. R. 4106

IN THE HOUSE OF REPRESENTATIVES

June 14, 2023

Ms. Crockett (for herself and Mr. Gooden of Texas) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To amend the 21st Century Cures Act to expressly authorize the use of certain grants to implement substance use disorder and overdose prevention activities with respect to fentanyl and xylazine test strips.

1.

Short title

This Act may be cited as the Test Strip Access Act of 2023.

2.

Grant program for State and Tribal response to opioid use disorders

Section 1003(b)(4)(A) of the 21st Century Cures Act (42 U.S.C. 290ee–3a(b)(4)(A)) is amended after which may include drugs or devices approved, cleared, or otherwise legally marketed under the Federal Food, Drug, and Cosmetic Act by inserting or fentanyl or xylazine test strips.